IRIS
VITALE, ANTONIO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 7.369
EU - Europa 7.218
AS - Asia 1.129
AF - Africa 34
SA - Sud America 27
OC - Oceania 11
Continente sconosciuto - Info sul continente non disponibili 5
Totale 15.793
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 7.360
GB - Regno Unito 2.565
IT - Italia 1.172
IE - Irlanda 984
CN - Cina 654
UA - Ucraina 578
SE - Svezia 524
RU - Federazione Russa 517
DE - Germania 279
SG - Singapore 272
FR - Francia 266
FI - Finlandia 188
VN - Vietnam 74
TR - Turchia 34
NL - Olanda 29
BE - Belgio 27
IN - India 26
CZ - Repubblica Ceca 23
CI - Costa d'Avorio 22
PL - Polonia 21
PK - Pakistan 18
BR - Brasile 17
ES - Italia 12
AU - Australia 9
JP - Giappone 9
IR - Iran 8
CA - Canada 7
HK - Hong Kong 6
EU - Europa 5
GR - Grecia 5
MA - Marocco 5
PT - Portogallo 4
SA - Arabia Saudita 4
AR - Argentina 3
BD - Bangladesh 3
EG - Egitto 3
HU - Ungheria 3
MY - Malesia 3
PE - Perù 3
RO - Romania 3
AL - Albania 2
BY - Bielorussia 2
CH - Svizzera 2
EC - Ecuador 2
ET - Etiopia 2
IL - Israele 2
KE - Kenya 2
KR - Corea 2
KZ - Kazakistan 2
LT - Lituania 2
LV - Lettonia 2
NZ - Nuova Zelanda 2
PA - Panama 2
RS - Serbia 2
SK - Slovacchia (Repubblica Slovacca) 2
AM - Armenia 1
AT - Austria 1
AZ - Azerbaigian 1
BG - Bulgaria 1
BO - Bolivia 1
CL - Cile 1
CY - Cipro 1
DK - Danimarca 1
ID - Indonesia 1
IQ - Iraq 1
KG - Kirghizistan 1
LA - Repubblica Popolare Democratica del Laos 1
LK - Sri Lanka 1
LU - Lussemburgo 1
NP - Nepal 1
TH - Thailandia 1
TM - Turkmenistan 1
UZ - Uzbekistan 1
Totale 15.793
Salva come PNG Salva come JPEG
Città #
Southend 2.456
Fairfield 1.212
Dublin 970
Ashburn 645
Woodbridge 565
Jacksonville 473
Wilmington 468
Chandler 463
Seattle 461
Houston 445
Cambridge 420
Siena 350
Ann Arbor 326
Menlo Park 319
Princeton 233
Singapore 183
Nanjing 151
New York 137
Beijing 134
Helsinki 106
San Mateo 86
Milan 85
Dong Ket 73
Dearborn 72
San Diego 72
Boardman 64
Nanchang 58
Rome 58
Moscow 42
Shenyang 42
Düsseldorf 35
Florence 30
Shanghai 30
Tianjin 29
Jiaxing 27
Izmir 26
Washington 26
Hebei 25
Changsha 24
Brussels 23
Abidjan 22
Munich 22
Norwalk 21
Kraków 20
Bologna 19
Los Angeles 19
Olomouc 18
Jinan 17
Kunming 17
Santa Clara 17
Turin 17
San Francisco 15
Guangzhou 14
London 14
Redwood City 13
Frankfurt am Main 11
Padova 11
Saint Petersburg 11
Livorno 10
Málaga 10
Tappahannock 10
Cecina 9
Lancaster 9
Monza 9
Sutri 9
Zhengzhou 9
Changchun 8
Dallas 8
Hangzhou 8
Lahore 8
Lanzhou 8
Perugia 8
Taizhou 8
Bari 7
Cagliari 7
Falls Church 7
Genoa 7
Naples 7
Palermo 7
Venezia 7
Asciano 6
Bergamo 6
Campi Bisenzio 6
Catania 6
Fort Worth 6
Lucca 6
Salerno 6
Brindisi 5
Cardiff 5
Fremont 5
Ningbo 5
Paris 5
Pavia 5
Ravenna 5
Reggio Emilia 5
Seveso 5
São Paulo 5
Uzzano 5
Venice 5
Verona 5
Totale 12.029
Salva come PNG Salva come JPEG
Nome #
VEXAS syndrome: a new paradigm for adult-onset monogenic autoinflammatory diseases 497
Cumulative retention rate of adalimumab in patients with Behçet's disease-related uveitis: A four-year follow-up study 256
Ten-Year Retention Rate of Infliximab in Patients with Behçet’s Disease-Related Uveitis 245
Long-term retention rates of adalimumab and infliximab in non-infectious intermediate, posterior, and panuveitis 232
Comparative efficacy between adalimumab and infliximab in the treatment of non-infectious intermediate uveitis, posterior uveitis, and panuveitis: a retrospective observational study of 107 patients 212
Efficacy of adalimumab and infliximab in recalcitrant retinal vasculitis inadequately responsive to other immunomodulatory therapies 201
A Snapshot on the On-Label and Off-Label Use of the Interleukin-1 Inhibitors in Italy among Rheumatologists and Pediatric Rheumatologists: A Nationwide Multi-Center Retrospective Observational Study 200
Auditory involvement in Behcet’s disease: relationship with demographic, clinical, and therapeutic characteristics 198
A comprehensive comparison between pediatric and adult patients with periodic fever, aphthous stomatitis, pharyngitis, and cervical adenopathy (PFAPA) syndrome 190
Weekly oral alendronate in mevalonate kinase deficiency 189
Quality of life impairment in Behçet’s disease and relationship with disease activity: a prospective study 189
Rapid and Sustained Efficacy of Golimumab in the Treatment of Multirefractory Uveitis Associated with Behçet’s Disease 186
Safety profile of the interleukin-1 inhibitors anakinra and canakinumab in real-life clinical practice: a nationwide multicenter retrospective observational study 181
The Presence of Uveitis Is Associated with a Sustained Response to the Interleukin (IL)-1 Inhibitors Anakinra and Canakinumab in Behçet's Disease 180
Biological treatments: new weapons in the management of monogenic autoinflammatory disorders 178
The diagnostic evaluation of patients with a suspected hereditary periodic fever syndrome: experience from a referral center in Italy 178
Predictors of sustained clinical response in patients with Behçet’s disease-related uveitis treated with infliximab and adalimumab 176
Caveats and truths in genetic, clinical, autoimmune and autoinflammatory issues in Blau syndrome and early onset sarcoidosis 171
Systemic Steroid Sparing Effect of Intravitreal Dexamethasone Implant in Chronic Noninfectious Uveitic Macular Edema 170
Working the endless puzzle of hereditary autoinflammatory disorders. 169
Certolizumab Pegol treatment in Behcet’s disease with different organ involvement: a multicenter retrospective observational study 167
Efficacy and safety of anakinra in tumor necrosis factor receptor-associated periodic syndrome (TRAPS) complicated by severe renal failure: a report after long-term follow-up and review of the literature 164
Switch from infliximab to infliximab biosimilar: efficacy and safety in a cohort of patients with different rheumatic diseases: Response to: Nikiphorou E, Kautiainen H, Hannonen P, et al. Clinical effectiveness of CT-P13 (Infliximab biosimilar) used as a switch from Remicade (infliximab) in patients with established rheumatic disease. Report of clinical experience based on prospective observational data. Expert Opin Biol Ther. 2015;15:1677–1683 161
Efficacy and Safety of Adalimumab in Behçet’s disease related uveitis: a multicenter retrospective observational study 159
Long-term efficacy and safety of golimumab in the treatment of multirefractory Behçet’s disease 159
Challenges and new horizons in the periodic fever, aphthous stomatitis, pharyngitis and adenitis (PFAPA) syndrome 158
Adalimumab effectiveness in Behçet’s disease: short and long-term data from a multicenter retrospective observational study 158
Impact of Uveitis on Quality of Life: A Prospective Study from a Tertiary Referral Rheumatology-Ophthalmology Collaborative Uveitis Center in Italy 154
null 150
Immunometabolic biomarkers of inflammation in Behçet's disease: Relationship with epidemiological profile, disease activity and therapeutic regimes 148
The hereditary autoinflammatory disorders uncovered 147
Correlation between serum amyloid-A and serum levels of proinflammatory cytokines in patients with Behçet's disease 147
The eye involvement in monogenic autoinflammatory diseases: Literature review and update 147
Interleukin (IL)-1 inhibition with anakinra and canakinumab in Behçet’s disease-related uveitis: a multicenter retrospective observational study 144
Diagnostic criteria for adult-onset periodic fever, aphthous stomatitis, pharyngitis, and cervical adenitis (PFAPA) syndrome 143
Correlation of Serum Amyloid-A Levels, Clinical Manifestations, Treatment, and Disease Activity in Patients with Behçet's Disease 143
The diagnostic evaluation of patients with potential adult-onset autoinflammatory disorders: our experience and review of the literature 143
Coexistence of axial spondyloarthritis and thromboangiitis obliterans in a young woman 140
Clinical and biochemical landmarks in systemic autoinflammatory diseases 139
The common NOD2/CARD15 variant P268S in patients with non-infectious uveitis: a cohort study 137
Childhood versus adulthood-onset autoinflammatory disorders: myths and truths intertwined 136
Adalimumab effectively controls both anterior and posterior noninfectious uveitis associated with systemic inflammatory diseases: focus on Behçet’s syndrome 135
Critical regulation of Th17 cell differentiation by serum amyloid-A signalling in Behcet's disease 134
Interleukin-1 as a common denominator from autoinflammatory to autoimmune disorders: premises, perils, and perspectives 134
Behçet’s syndrome in Italy: a detailed retrospective analysis of 396 cases seen in 3 tertiary referral clinics 134
Treating juvenile idiopathic arthritis (JIA)-related uveitis beyond TNF-α inhibition: a narrative review 133
Relapsing Polychondritis: an Update on Pathogenesis, Clinical Features, Diagnostic Tools, and Therapeutic Perspectives 132
The role of the F402L allele in the NLRP12-autoinflammatory disorder. Reply to: F402L variant in NLRP12 in subjects with undiagnosed periodic fevers and in healthy controls 132
null 131
Idiopathic inflammatory myopathies: an update on classification and treatment with special focus on juvenile forms 129
Long-term efficacy and safety of the interleukin-1 inhibitors anakinra and canakinumab in refractory Behçet disease uveitis and concomitant bladder papillary carcinoma 129
Mucocutaneous Involvement in Behçet's Disease: How Systemic Treatment Has Changed in the Last Decades and Future Perspectives 129
The expanding spectrum of low-penetrance TNFRSF1A gene variants in adults presenting with recurrent inflammatory attacks: Clinical manifestations and long-term follow-up 128
Long-term efficacy and safety of anakinra in a patient with Behçet's disease and concomitant tuberculosis infection 128
Adalimumab-Based Treatment Versus Disease-Modifying Antirheumatic Drugs for Venous Thrombosis in Behçet's Syndrome: A Retrospective Study of Seventy Patients With Vascular Involvement 128
Diagnosis and classification of relapsing polychondritis 127
Monogenic autoinflammatory syndromes: state of the art on genetic, clinical, and therapeutic issues 126
A case of resistant adult-onset periodic fever, aphthous stomatitis, pharyngitis and cervical adenitis (PFAPA) syndrome responsive to anakinra. 125
Key facts and hot spots on tumor necrosis factor receptor-associated periodic syndrome 125
Serum amyloid-A in Behçet's disease 124
Circulating intercellular adhesion molecule 1 (sICAM-1) in tumour necrosis factor receptor-associated periodic syndrome (TRAPS) 121
null 121
Long-term safety of anti-TNF agents on the liver of patients with spondyloarthritis and potential occult hepatitis B viral infection: An observational multicentre study 120
null 119
Inhibition of Interleukin-1 by Canakinumab as a Successful Mono-Drug Strategy for the Treatment of Refractory Behçet's Disease: A Case Series 118
null 118
Anakinra long-term efficacy and safety in the management of Schnitzler's syndrome and latent tuberculosis infection 118
Paradoxical mucocutaneous flare in a case of Behçet's disease treated with tocilizumab 118
Prompt Clinical Response to Secukinumab in Patients with Axial Spondyloarthritis: Real Life Observational Data from Three Italian Referral Centers 118
null 117
null 116
Role of Colchicine Treatment in Tumor Necrosis Factor Receptor Associated Periodic Syndrome (TRAPS): Real-Life Data from the AIDA Network 116
Clues to detect tumor necrosis factor receptor-associated periodic syndrome (TRAPS) among patients with idiopathic recurrent acute pericarditis: results of a multicentre study 116
null 115
null 115
null 113
null 112
Long-Term Outcomes of Behçet's Syndrome-Related Uveitis: A Monocentric Italian Experience 111
null 107
null 107
Proinflammatory Cytokines and Antiskin Autoantibodies in Patients With Inherited Epidermolysis Bullosa 105
Evolving Frontiers in the Treatment of Periodic Fever, Aphthous Stomatitis, Pharyngitis, Cervical Adenitis (PFAPA) Syndrome 104
null 104
null 102
The most recent advances in pathophysiology and management of tumour necrosis factor receptor-associated periodic syndrome (TRAPS): personal experience and literature review 99
null 98
Adalimumab Accounts for Long-Term Control of Noninfectious Uveitis Also in the Absence of Concomitant DMARD Treatment: A Multicenter Retrospective Study 98
Diagnosis of PFAPA syndrome applied to a cohort of 17 adults with unexplained recurrent fevers 97
Rare NLRP12 variants associated with the NLRP12-autoinflammatory disorder phenotype: an Italian case series 96
null 95
null 94
Comparison of Early vs. Delayed Anakinra Treatment in Patients With Adult Onset Still's Disease and Effect on Clinical and Laboratory Outcomes 93
Interleukin-1: Ariadne's Thread in Autoinflammatory and Autoimmune Disorders 91
Hints for Genetic and Clinical Differentiation of Adult-Onset Monogenic Autoinflammatory Diseases 91
Successful use of canakinumab in a patient with resistant Behçet's disease 90
Efficacy of anakinra in refractory Behçet's disease sacroiliitis 88
Expanding spectrum of TNFRSF1A gene mutations among patients with idiopathic recurrent acute pericarditis 86
Long-term clinical course of patients carrying the Q703K mutation in the NLRP3 gene: a case series 85
Autoinflammatory diseases 83
Leptin, adiponectin, resistin, visfatin serum levels and idiopathic recurrent pericarditis: biomarkers of disease activity? A preliminary report 82
Totale 14.002
Salva come PNG Salva come JPEG
Categoria #
all - tutte 47.837
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 47.837
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20201.991 0 0 0 0 166 276 260 373 310 317 103 186
2020/20212.673 251 260 108 220 190 353 105 396 119 262 154 255
2021/20221.917 183 234 118 134 99 35 82 64 142 231 205 390
2022/20231.801 116 151 244 220 168 341 54 140 209 24 78 56
2023/20241.952 78 47 173 109 96 517 550 81 17 68 65 151
2024/20251.386 263 221 525 270 107 0 0 0 0 0 0 0
Totale 16.342